Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,198 | -20,719 | -29,247 | -32,813 | -24,559 |
| Depreciation Amortization | 2,451 | 2,125 | 2,023 | 1,132 | 1,130 |
| Accounts receivable | 423 | -1,720 | -246 | -1,288 | 421 |
| Other Working Capital | -1,030 | -4,379 | 2,649 | -3,562 | 642 |
| Other Operating Activity | -6,023 | 10,265 | 3,165 | 8,297 | 8,361 |
| Operating Cash Flow | $-12,377 | $-14,428 | $-21,655 | $-28,234 | $-14,006 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -88 | -284 | -538 | -6,087 | -3,641 |
| Purchase Sale Intangibles | -327 | -385 | -398 | -368 | -640 |
| Other Investing Activity | -327 | -385 | -398 | -368 | -640 |
| Investing Cash Flow | $-415 | $-669 | $-936 | $-6,456 | $-4,281 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,478 | 15,000 | N/A | 5,000 | 0 |
| Debt Repayment | 0 | -5,000 | N/A | N/A | N/A |
| Common Stock Issued | 6,831 | N/A | 218 | 0 | 805 |
| Other Financing Activity | 0 | -669 | 14,256 | -40 | -90 |
| Financing Cash Flow | $9,309 | $9,331 | $14,474 | $4,960 | $715 |
| Exchange Rate Effect | 1,490 | -85 | -100 | -263 | -25 |
| Beginning Cash Position | 9,764 | 15,615 | 23,832 | 53,825 | 71,422 |
| End Cash Position | 7,771 | 9,764 | 15,615 | 23,832 | 53,825 |
| Net Cash Flow | $-1,993 | $-5,851 | $-8,217 | $-29,993 | $-17,596 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,377 | -14,428 | -21,655 | -28,234 | -14,006 |
| Capital Expenditure | -164 | -284 | -538 | -6,087 | -3,641 |
| Free Cash Flow | -12,541 | -14,712 | -22,193 | -34,322 | -17,647 |